If you are interested in keeping up to date with stocks making moves within the biotech, pharma and healthcare industries, and understanding the key trends and catalysts driving valuations ahead of the market, why not subscribe to my weekly newsletter via my Investing Group, Haggerston BioHealth ?Novo's tough 2025 continued with announcement this morning that it was cutting jobs and slashing profit guidance. While the news is somewhat shocking given the supreme potential of its best-selling drug molecule, s ...